Nagai H, Yakuo I, Yamada H, Shimazawa T, Koda A, Niu K, Asano K, Shimizu T, Kasahara M
Department of Pharmacology, Gifu Pharmaceutical University, Japan.
Jpn J Pharmacol. 1988 Mar;46(3):247-54. doi: 10.1254/jjp.46.247.
Experimental liver injury was produced in mice by the immunological technique. The utility of these models as an immunopharmacological method was investigated. The first model was produced by the injection of anti-basic liver protein (BLP) rabbit antibody into DBA/2 mice that had been previously immunized with rabbit IgG. The second liver injury was caused by injection of anti-liver specific protein (LSP) rabbit antibody into DBA/2 mice. The third model was produced by the injection of bacterial lipopolysaccharide (LPS) into Corynebacterium parvum pretreated ddY mice. In all injury models, extensive liver parenchymal cell damage was estimated by elevation of glutamate transaminase (GOT and GPT) activity. These were confirmed by histopathological studies of the liver. Typical histopathological changes in the liver from injured mice were submassive hepatocellular necrosis and infiltration of granulocytes and lymphocytes into the portal tract and sinusoid in the necrotic lesion. Administration of prednisolone and cyclophosphamide for 10 days prior to injection of eliciting antibodies or LPS suppressed the elevation of serum transaminase levels in all experimental liver injury models. Cianidanol and sylibin inhibited the elevation of GOT and GPT in anti-BLP induced liver injured mice. These evidences suggest that the above models are suitable for investigating the remedy for liver diseases.
采用免疫技术在小鼠中诱导实验性肝损伤。研究了这些模型作为免疫药理学方法的实用性。第一种模型是通过向预先用兔IgG免疫的DBA/2小鼠注射抗碱性肝蛋白(BLP)兔抗体产生的。第二种肝损伤是通过向DBA/2小鼠注射抗肝特异性蛋白(LSP)兔抗体引起的。第三种模型是通过向短小棒状杆菌预处理的ddY小鼠注射细菌脂多糖(LPS)产生的。在所有损伤模型中,通过谷氨酸转氨酶(GOT和GPT)活性升高来评估广泛的肝实质细胞损伤。这些通过肝脏的组织病理学研究得到证实。受损小鼠肝脏典型的组织病理学变化为亚大块肝细胞坏死以及粒细胞和淋巴细胞浸润到坏死病变的门静脉和肝血窦中。在注射引发抗体或LPS前10天给予泼尼松龙和环磷酰胺可抑制所有实验性肝损伤模型中血清转氨酶水平的升高。齐墩果酸和水飞蓟宾抑制抗BLP诱导的肝损伤小鼠中GOT和GPT的升高。这些证据表明上述模型适用于研究肝脏疾病的治疗方法。